ABDXF (Abingdon Health) Asset Turnover: 0.42 (As of Dec. 2025)


ABDXF Abingdon Health PLC ABDXF
49 GF Score
Price $0.15
GF Value $0.21
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Abingdon Health Asset Turnover?

Abingdon Health ABDXF +8.93% 49 Asset Turnover is 0.42 as of Dec. 2025. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.21 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Abingdon Health's Revenue for the six months ended in Dec. 2025 was $5.67 Mil. Abingdon Health's Total Assets for the quarter that ended in Dec. 2025 was $13.38 Mil. Therefore, Abingdon Health's Asset Turnover for the quarter that ended in Dec. 2025 was 0.42.

Asset Turnover is linked to ROE % through Du Pont Formula. Abingdon Health's annualized ROE % for the quarter that ended in Dec. 2025 was -80.51%. It is also linked to ROA % through Du Pont Formula. Abingdon Health's annualized ROA % for the quarter that ended in Dec. 2025 was -47.01%.

Abingdon Health  (OTCPK:ABDXF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Abingdon Health's annulized ROE % for the quarter that ended in Dec. 2025 is

ROE %**(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-6.29/7.813
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-6.29 / 11.344)*(11.344 / 13.3815)*(13.3815/ 7.813)
=Net Margin %*Asset Turnover*Equity Multiplier
=-55.45 %*0.8477*1.7127
=ROA %*Equity Multiplier
=-47.01 %*1.7127
=-80.51 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Abingdon Health's annulized ROA % for the quarter that ended in Dec. 2025 is

ROA %(Q: Dec. 2025 )
=Net Income/Total Assets
=-6.29/13.3815
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.29 / 11.344)*(11.344 / 13.3815)
=Net Margin %*Asset Turnover
=-55.45 %*0.8477
=-47.01 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Abingdon Health Asset Turnover Related Terms

Abingdon Health Asset Turnover Historical Data

* Premium members only.

The historical data trend for Abingdon Health's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abingdon Health Asset Turnover Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Asset Turnover
Get a 7-Day Free Trial 0.54 0.11 0.43 1.10 1.20

Abingdon Health Semi-Annual Data
Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.75 0.41 0.58 0.42

ABDXF vs TMO, DHR, IDXX: Asset Turnover Comparison

For the Diagnostics & Research subindustry, Abingdon Health's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abingdon Health Asset Turnover vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Asset Turnover falls into.


ABDXF
49GF Score
Abingdon Health PLC ABDXF
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abingdon Health Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Abingdon Health's Asset Turnover for the fiscal year that ended in Jun. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2025 )/( (Total Assets (A: Jun. 2024 )+Total Assets (A: Jun. 2025 ))/ count )
=11.437/( (6.476+12.636)/ 2 )
=11.437/9.556
=1.20

Abingdon Health's Asset Turnover for the quarter that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=5.672/( (12.636+14.127)/ 2 )
=5.672/13.3815
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.42 mean?
Abingdon Health (ABDXF) has a Asset Turnover of 0.42 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Abingdon Health and its competitors.
Is Abingdon Health's Asset Turnover too high?
Abingdon Health's current Asset Turnover is 0.42. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Asset Turnover compare to TMO and DHR?
Abingdon Health's Asset Turnover of 0.42 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Diagnostics & Research company?
A good Asset Turnover depends on the Medical Diagnostics & Research industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Abingdon Health and its competitors. Abingdon Health's current Asset Turnover is 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.21, compared to a current price of $0.15 — trading 27.4% below its estimated fair value. The current Asset Turnover is 0.42. Abingdon Health's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Asset Turnover is 0.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abingdon Health (ABDXF) Overvalued in 2026?

Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued. The current stock price of $0.15 is trading 27.4% below its estimated GF Value™ of $0.21. GuruFocus considers Abingdon Health to be Modestly Undervalued.

Key valuation signals for ABDXF:

  • Asset Turnover: 0.42
  • GF Value™: $0.21 vs. price of $0.15 (27.4% below fair value)
  • GF Score™: 49/100 with 9 warning signs

No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abingdon Health Business Description

Other Exchanges ABDX:UK
Address York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score

Get the complete analysis for ABDXF

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.21
GF Value